Manipal Health Q1 FY27 results................

Manipal Health reported a strong topline performance in Q1 FY27, with healthy growth in revenue and operating profit. However, net profit declined due to the impact of exceptional items. Sales: ↑ 38% YoY to ₹3,091 crore (vs ₹2,238 crore in Q1 FY26) EBIDT: ↑ 26% YoY to ₹737 crore (vs ₹586 crore) Net Profit: ↓ 8% YoY to ₹243 crore (vs ₹254 crore) EPS: ↓ 10% YoY to ₹1.96 (vs ₹2.17) Exceptional Items Impact: Jun 2026: -₹15.5 crore Jun 2025: -₹18.4 crore (Note: Exceptional items are excluded in YoY growth calculation) At a price of ₹757, market cap ₹99,521 crore, and PE 112.4, the company delivered strong operational growth, but bottom-line performance was impacted due to exceptional adjustments.